← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 24, 2018Last known activity
Feb 1, 2026
Timeline
2010s
- Jun 1, 2015
Arcus Biosciences, Inc.— Founded
Drugs by trial phase (34 distinct, 47 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Endometrial Neoplasms
- Glioblastoma
- Lung Neoplasms
- Neoplasms
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07283848CollaboratorPhase 2Feb 1, 2026
- NCT07011719Lead sponsorPhase 3Sep 8, 2025
- NCT07011719OfficialPhase 3Sep 8, 2025
- NCT07000149CollaboratorPhase 3Jul 28, 2025
- NCT06919991Lead sponsorPhase 1May 2, 2025
- NCT06919991OfficialPhase 1May 2, 2025
- NCT06727565CollaboratorPhase 2Dec 31, 2024
- NCT06608927Lead sponsorPhase 3Nov 30, 2024
- NCT06608927OfficialPhase 3Nov 30, 2024
- NCT06191796CollaboratorPhase 1/Phase 2Jan 25, 2024
- NCT06048133CollaboratorPhase 2Dec 31, 2023
- NCT06120075Study directorPhase 1Dec 1, 2023
- NCT06120075Lead sponsorPhase 1Dec 1, 2023
- NCT06048484CollaboratorPhase 2Oct 31, 2023
- NCT06004921Study directorPhase 1Oct 16, 2023
Details
- Founded
- Hayward, CA, US Jun 1, 2015
- Last known activity
- Feb 1, 2026